Meghmani Organics Q4 FY26: Margins compressed, Brazil and nano fertilisers become key levers

Meghmani Organics Limited closed FY26 with modest top-line growth but a sharp end-of-year profitability reset. On a standalone basis, revenue from operations for FY26 was INR 2,091.8 crore, up 4% year on year. EBITDA rose to INR 228.7 crore, up 27% year on year, while PAT increased to INR 125.3 crore.

The quarter told a different story. Standalone revenue in Q4 FY26 was INR 456.6 crore, down 9% year on year, and EBITDA fell to INR 26.2 crore compared with INR 64.6 crore in Q4 FY25. Management attributed the weak quarter to softer demand in exports due to macro uncertainty, rising input costs, and broadly stable realizations, which compressed margins.

The company’s operating profile remains anchored in Crop Protection, supported by a smaller but global Pigments business, alongside newer bets in Crop Nutrition and Titanium Dioxide through wholly-owned subsidiaries.

FY26 and Q4 FY26 snapshot: topline steady, volatility in profitability

Standalone FY26 gross margin improved slightly to 39.0% from 38.2% in FY25, while EBITDA margin expanded to 10.9% from 9.0%. However, Q4 FY26 EBITDA margin dropped to 5.7% from 12.9% a year earlier, reflecting the sharp rise in input costs that could not be passed through immediately.

On a consolidated basis, FY26 revenue from operations was INR 2,174.0 crore, up 5% year on year, and EBITDA was INR 176.4 crore, up 24% year on year. Consolidated EBITDA margin was 8.1%.

Segment performance: Crop Protection strong for the year, Pigments still weak

Crop Protection remained the dominant contributor. In FY26, Crop Protection revenue was INR 1,631.2 crore with exports at 87%. Segment EBITDA was INR 243.6 crore and EBITDA margin was 14.9%. Capacity utilization for FY26 was stated at 72%.

In Q4 FY26, Crop Protection revenue was INR 348.6 crore and segment EBITDA was INR 31.3 crore. The segment’s EBITDA margin fell to 9.0% in the quarter, highlighting the impact of raw material inflation and timing mismatch in passing through price increases.

Pigments continued to face demand and utilization challenges. FY26 pigments revenue was INR 460.6 crore, with 78% exports. Segment EBITDA was INR 15.0 crore and EBITDA margin was 3.3%. Capacity utilization for FY26 was disclosed at 40%.

In Q4 FY26, Pigments revenue was INR 108.0 crore and segment EBITDA was INR 3.2 crore with a 3.0% margin. Production volumes declined materially year on year in the quarter.

Management indicated that Pigments may see better profitability in FY27 versus FY26, though it did not guide for meaningful top-line growth and described the revenue range expectation at about INR 500 to INR 600 crore for the segment.

Strategy and execution: Brazil expansion, nano fertilisers ramp, and entity simplification

A key strategic development discussed in the concall was the establishment of a wholly-owned subsidiary in Brazil. Management described Brazil as one of the world’s largest agrochemical markets and emphasized that it has high entry barriers due to the time and cost required for registrations. The company positioned this move as a step to strengthen market access and as a growth driver going forward.

The company also highlighted the Multi Purpose Plant at Dahej with 5,000 MTPA installed capacity to manufacture new-age, high value insecticides. The presentation stated that the capex allows MOL to compete more directly with multinational players and align with China Plus One sourcing opportunities.

In Crop Nutrition, the company has already commissioned a nano urea liquid fertilizer plant at Sanand with installed capacity of 5 crore 500 ml bottles per year. Management said it received approvals from the Ministry of Agriculture and Farmers Welfare for Nano DAP, Nano NPK and Nano Zinc and plans to start commercial production during the Kharif season in FY27, using existing infrastructure and without additional capital expenditure.

A corporate restructuring is also underway. The company filed a scheme of amalgamation under which Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited will be merged into Meghmani Organics Limited. The stated rationale includes simplification of group structure, reduced duplicate compliances, and operational and financial synergies. Management also spoke about combining customer-facing teams and improving utilization of resources across entities.

TiO2: operations suspended amid cost and pricing pressures

Titanium Dioxide under Kilburn Chemicals was the most explicit risk disclosure in the call. Management stated operations were temporarily suspended due to commercial unviability. It cited elevated raw material costs, especially sulphuric acid, and weaker price realizations after the withdrawal of anti-dumping duty. Management also said the anti-dumping matter is under review with DGTR and it expects an announcement in one to two months, but emphasized that raw material normalization remains difficult to predict given geopolitical factors.

What management guided for FY27

Management did not provide detailed financial guidance for FY27 at the consolidated level. However, it made a few clear statements.

First, it expects FY27 to be better than FY26 in revenue and profitability and indicated it may consider paying a dividend in FY27, subject to board approval.

Second, it reiterated a long-term Crop Protection EBITDA margin band of 15% to 17% and stated it expects to be in this range in FY27, while also describing Q4 FY26 as an odd quarter due to sudden cost spikes and delay in passing on price increases.

Third, it guided that capex in FY27 will be routine, around INR 35 to 40 crore, and not a significant capex year.

Finally, it stated it is working on rationalizing inventory and reducing receivables to improve working capital.

Closing view

Meghmani Organics ended FY26 with a better full-year EBITDA and PAT versus FY25, but the Q4 FY26 margin drop showed how sensitive earnings can be to input cost spikes and export market disruptions. The strategic priorities for FY27 are now clearer: strengthen Crop Protection with higher value products and deeper Brazil presence, accelerate Crop Nutrition with additional nano fertilisers, and simplify the group structure via amalgamation.

At the same time, the temporary suspension of TiO2 operations underscores the need for a more stable domestic pricing environment and a more predictable raw material cost curve. FY27 will likely be judged on whether Crop Protection margins normalize back toward the guided band and whether the newer growth levers translate into visible, repeatable earnings.